Advanced Her2 Expressing Solid Tumors clinical trials

Explore recruiting advanced her2 expressing solid tumors clinical trials.

Recruiting advanced her2 expressing solid tumors studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Advanced Her2 Expressing Solid Tumors trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Phase 1/2 Study of BDC-1001 as a Single Agent and in Combination with Nivolumab in Patients with Advanced HER2-Expressing Solid Tumors

France

Phase I and Phase II (Integrated)- Other EU CTIS Study details

Advanced Her2 Expressing Solid Tumors trials by city

Advanced Her2 Expressing Solid Tumors in Toronto Advanced Her2 Expressing Solid Tumors in Vancouver Advanced Her2 Expressing Solid Tumors in Montreal Advanced Her2 Expressing Solid Tumors in Calgary Advanced Her2 Expressing Solid Tumors in Edmonton Advanced Her2 Expressing Solid Tumors in Ottawa Advanced Her2 Expressing Solid Tumors in Winnipeg Advanced Her2 Expressing Solid Tumors in Quebec City Advanced Her2 Expressing Solid Tumors in Hamilton Advanced Her2 Expressing Solid Tumors in Kitchener Advanced Her2 Expressing Solid Tumors in London Advanced Her2 Expressing Solid Tumors in Halifax Advanced Her2 Expressing Solid Tumors in New York Advanced Her2 Expressing Solid Tumors in Los Angeles Advanced Her2 Expressing Solid Tumors in Chicago Advanced Her2 Expressing Solid Tumors in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease